# ALP Bio

**Source:** https://www.startuphub.ai/startups/alp-bio
**Profile type:** Startup

> Combines human immune organoid biology with generative AI to reduce immunogenicity risk in antibody development.

## About

ALP Bio AG is a Swiss biotech startup developing a platform that integrates human immune organoid biology with generative AI. Their goal is to help antibody developers identify, understand, and reduce immunogenicity risk earlier in the drug development process. The platform leverages human tonsil organoid technology to model immune activity in vitro and employs AI models to learn from biological datasets. This hybrid approach aims to provide more clinically relevant signals for earlier decision-making in antibody development, supporting lead candidate screening, ADA risk stratification, and sequence optimization.

## Key facts

- **Slug:** alp-bio
- **Website:** https://alp.bio
- **Location:** Schlieren, Zurich, Switzerland
- **Founded:** 2025-01-01T00:00:00
- **Operating status:** Active
- **Total funding:** $2M
- **Sectors / tags:** Biotechnology, Artificial Intelligence, Drug Discovery, Pharmaceuticals, Biotech, AI-Driven Drug Discovery, Organoid Intelligence, Generative AI, Antibody Development, Immunogenicity, Therapeutic Antibodies, Biologics
- **Social:**
  - LinkedIn: https://www.linkedin.com/in/christian-vahlensieck-239a9b140

## Frequently asked

### What does ALP Bio do?

ALP Bio AG is a Swiss biotech startup developing a platform that integrates human immune organoid biology with generative AI. Their goal is to help antibody developers identify, understand, and reduce immunogenicity risk earlier in the drug development process. The platform leverages human tonsil organoid technology to model immune activity in vitro and employs AI models to learn from biological datasets. This hybrid approach aims to provide more clinically relevant signals for earlier decision-…

### What is ALP Bio's revenue?

StartupHub estimates ALP Bio's annual revenue at $318K (range $109K to $928K, 34% confidence), based on comparable companies in the sector.

### What is ALP Bio's valuation?

StartupHub estimates ALP Bio's effective valuation at $8.1M (range $5.2M to $12.5M, 24% confidence), based on comparable companies in the sector.

### How much funding has ALP Bio raised?

ALP Bio has raised a total of $2M in funding. The most recent round on record is Pre-Seed.

### Where is ALP Bio headquartered?

ALP Bio is headquartered in Schlieren, Zurich, Switzerland.

### When was ALP Bio founded?

ALP Bio was founded in 2025.

### What industry does ALP Bio operate in?

ALP Bio operates in Biotechnology, Artificial Intelligence, Drug Discovery, Pharmaceuticals, Biotech, AI-Driven Drug Discovery.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "ALP Bio",
          "item": "https://www.startuphub.ai/startups/alp-bio"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/alp-bio#webpage",
      "url": "https://www.startuphub.ai/startups/alp-bio",
      "name": "ALP Bio - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of ALP Bio. ALP Bio is a startup founded in 2025, operating in Biotechnology and Artificial Intelligence. Combines human immune organoid biology with generative AI to reduce immunogenicity risk in antibody development. Headquartered in Schlieren, Zurich, Switzerland.",
      "dateModified": "2026-07-03T08:18:11.139+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/alp-bio#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/alp-bio#organization",
      "name": "ALP Bio",
      "url": "https://alp.bio",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/6098563e-f4c4-42a2-9fb2-68f2901fb84c-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/6098563e-f4c4-42a2-9fb2-68f2901fb84c-square.webp",
      "description": "This is the official profile of ALP Bio. ALP Bio is a startup founded in 2025, operating in Biotechnology and Artificial Intelligence. Combines human immune organoid biology with generative AI to reduce immunogenicity risk in antibody development. Headquartered in Schlieren, Zurich, Switzerland.",
      "sameAs": [
        "https://www.linkedin.com/in/christian-vahlensieck-239a9b140",
        "https://www.startuphub.ai/startups/alp-bio"
      ],
      "foundingDate": "2025-01-01",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Schlieren",
        "addressRegion": "Zurich",
        "addressCountry": "Switzerland"
      },
      "knowsAbout": [
        "Biotechnology",
        "Artificial Intelligence",
        "Drug Discovery",
        "Pharmaceuticals",
        "Biotech",
        "AI-Driven Drug Discovery",
        "Organoid Intelligence",
        "Generative AI",
        "Antibody Development",
        "Immunogenicity",
        "Therapeutic Antibodies",
        "Biologics"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/alp-bio#profile-assessment",
      "name": "ALP Bio - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/alp-bio",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/6098563e-f4c4-42a2-9fb2-68f2901fb84c-square.webp",
      "category": "Biotechnology",
      "description": "This is the official profile of ALP Bio. ALP Bio is a startup founded in 2025, operating in Biotechnology and Artificial Intelligence. Combines human immune organoid biology with generative AI to reduce immunogenicity risk in antibody development. Headquartered in Schlieren, Zurich, Switzerland. Agent Readiness score: 33/100. Full audit: https://www.startuphub.ai/startups/alp-bio/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "ALP Bio"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-07-03",
        "name": "ALP Bio - Profile Score 44/100",
        "reviewBody": "This is the official profile of ALP Bio. ALP Bio is a startup founded in 2025, operating in Biotechnology and Artificial Intelligence. Combines human immune organoid biology with generative AI to reduce immunogenicity risk in antibody development. Headquartered in Schlieren, Zurich, Switzerland. Agent Readiness score: 33/100. Full audit: https://www.startuphub.ai/startups/alp-bio/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 44,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```